- $1.17bn
- $1.15bn
- $1.31bn
Annual balance sheet for Revelyst, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Cash and Short Term Investments | 15.5 | 22.9 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 202 | 211 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 664 | 557 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 171 | 161 |
| Net Goodwill | ||
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 1,951 | 1,575 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 204 | 206 |
| Total Long Term Debt | ||
| Total Debt | ||
| Deferred Income Tax | ||
| Total Other Liabilities | ||
| Total Liabilities | 365 | 341 |
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 1,586 | 1,234 |
| Total Liabilities & Shareholders' Equity | 1,951 | 1,575 |
| Total Common Shares Outstanding |